Sarepta Therapeutics Completes Submission of New Drug Application Seeking Approval of Golodirsen (SRP-4053)
Sarepta Announces Agreement with Nationwide Children’s Hospital for Rights to its Gene Therapy Program
US Capital Global Facilitates $50MM Financing to Accelerate Charbone Hydrogen's North American Expansion
